# WuXi AppTec Posts RMB 45.54 Billion Q1-Q3 Revenue and Lifts Full-Year Guidance

> WuXi AppTec lifted its 2026 revenue target to RMB 61.0-61.9 billion after Q1-Q3 revenue rose 38.6% to RMB 45.54 billion and adjusted net profit climbed 74.4%.

- Published: 2026-10-26T09:50:35+00:00
- Section: Earnings & Results
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-26/wuxi-apptec-raises-2026-revenue-guidance
- Source: [PR Newswire](https://www.prnewswire.com/news-releases/wuxi-apptec-delivers-strong-q1-q3-2026-results-and-further-raises-full-year-guidance-driven-by-greater-success-of-multiple-customers-products-and-crdmo-model-302919202.html)

## Key takeaways

- WuXi AppTec reported Q1-Q3 2026 revenue of RMB 45.54 billion, up 38.6% year-on-year.
- Adjusted non-IFRS net profit rose 74.4% to RMB 18.38 billion, and backlog for Continuing Operations reached RMB 76.74 billion.
- The company raised its 2026 total revenue target to RMB 61.0-61.9 billion from RMB 58.5-60.5 billion.

[WuXi AppTec](https://akta.pro/company-profiles/0000ca7/wuxi-apptec) reported Q1-Q3 2026 revenue of RMB 45.54 billion, up 38.6% year-on-year, and raised its full-year guidance, the company said in a [PR Newswire](https://www.prnewswire.com/news-releases/wuxi-apptec-delivers-strong-q1-q3-2026-results-and-further-raises-full-year-guidance-driven-by-greater-success-of-multiple-customers-products-and-crdmo-model-302919202.html) release on October 26, 2026. WuXi AppTec is a global CRDMO offering integrated pharmaceutical research, development and manufacturing services across small molecules, oligonucleotides, peptides and biologics, serving more than 6,000 pharma and biotech customers in 30+ countries.

## WuXi AppTec's Q1-Q3 2026 Results and Raised Guidance

Revenue from Continuing Operations rose 46.3% year-on-year, according to akta.pro [company records](https://akta.pro/company-data). Adjusted non-IFRS gross profit margin increased by 7.7 percentage points year-on-year to 54.8%, and adjusted non-IFRS net profit rose 74.4% to RMB 18.38 billion, with the adjusted non-IFRS net profit margin up 8.3 percentage points to 40.4%. Adjusted non-IFRS diluted EPS rose 68.8% to RMB 6.21, while net profit per CAS rose 60.6% to RMB 19.40 billion and diluted EPS rose 55.6% to RMB 6.55. Backlog for Continuing Operations rose 36.4% year-on-year to RMB 76.74 billion as of September 30, 2026, and adjusted operating cash flow rose 58.9% to RMB 17.28 billion.

Dr. Ge Li, Chairman and CEO of WuXi AppTec, said, "Enabling our customers and benefiting patients is the cornerstone of WuXi AppTec's sustained growth." He added that the company's backlog for Continuing Operations reached RMB 76.7 billion and that it has further raised its full-year guidance.

The company distributed RMB 6.22 billion in cash dividends in Q1-Q3, including RMB 4.71 billion for the 2025 annual dividend and RMB 1.51 billion for the 2026 interim dividend. WuXi AppTec raised its 2026 total revenue target to RMB 61.0-61.9 billion from RMB 58.5-60.5 billion, with Continuing Operations revenue now expected to grow 40-42% year-on-year from a previous 35-39%. The 2026 capex forecast was adjusted to RMB 8.0-8.5 billion from RMB 7.5-8.5 billion, and the 2026 adjusted free cash flow forecast was raised to RMB 14.5-15.5 billion from RMB 13.5-14.5 billion.

## WuXi AppTec's Earlier 2026 Milestones

Frost & Sullivan awarded WuXi AppTec the 2026 Global Company of the Year Recognition in the CRDMO industry for its integrated capabilities and global capacity, Newswire reported in October 2026. The company completed 741 regulatory inspections in 2025 with zero critical findings. In October 2026, PR Newswire reported that WuXi AppTec received a third consecutive EcoVadis Gold Medal, ranking among the global top 5% for sustainability.

## What Comes Next for WuXi AppTec

The 2026 capex forecast supports accelerated global capacity development, including initiation of the new Changzhou site ahead of schedule, according to the company.

## Companies in this story

- [WuXi AppTec company profile](https://akta.pro/company-profiles/0000ca7/wuxi-apptec) · website: https://www.wuxiapptec.com

---
News for Agent · https://newsforagent.com/llms.txt